Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 20

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease

Sola-Sevilla, Noemi, Mesa-Lombardo, Alberto, Aleixo, Mikel, Expósito, Sara, Diaz-Perdigón, Teresa, Azqueta, Amaya, Zamani, Farzad, Suzuki, Takayoshi, Maioli, Silvia, Eroli, Francesca, Matton, Anna, Ramírez, Maria J., Solas, Maite, Tordera, Rosa M., Martín, Eduardo D., Puerta, Elena · 2023 · Journal of Neuroimmune Pharmacology

Published version of a preprint

Abstract

Sirtuin 2 (SIRT2) has been proposed to have a central role on aging, inflammation, cancer and neurodegenerative diseases; however, its specific function remains controversial. Recent studies propose SIRT2 pharmacological inhibition as a therapeutic strategy for several neurodegenerative diseases including Alzheimer’s disease (AD). Surprisingly, none of these published studies regarding the potential interest of SIRT2 inhibition has assessed the peripheral adverse side consequences of this treatment. In this study, we demonstrate that the specific SIRT2 inhibitor, the compound 33i, does not exhibit genotoxic or mutagenic properties. Moreover, pharmacological treatment with 33i, improved cognitive dysfunction and long-term potentiation, reducing amyloid pathology and neuroinflammation in the APP/PS1 AD mouse model. However, this treatment increased peripheral levels of the inflammatory cytokines IL-1β, TNF, IL-6 and MCP-1. Accordingly, peripheral SIRT2 inhibition with the blood brain barrier impermeable compound AGK-2, worsened the cognitive capacities and increased systemic inflammation. The analysis of human samples revealed that SIRT2 is increased in the brain but not in the serum of AD patients. These results suggest that, although SIRT2 pharmacological inhibition may have beneficial consequences in neurodegenerative diseases, its pharmacological inhibition at the periphery would not be recommended and the systemic adverse side effects should be considered. This information is essential to maximize the therapeutic potential of SIRT2 inhibition not only for AD but also for other neurodegenerative diseases. Graphical Abstract

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11481-023-10084-9

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 61

  1. Azqueta A, Stopper H, Zegura B, Dusinska M, Møller P (2022) Do cytotoxicity and cell death cause false positive results in the in vitro comet assay? Mutat Res Genet Toxicol Environ Mutagen 881:503520. https://doi.org/10.1016/j.mrgentox.2022.503520 · DOI · Paper page
  2. Bai N, Li N, Cheng R, Guan Y, Zhao X, Song Z, Xu H, Yi F, Jiang B, Li X, Wu X, Jiang C, Zhou T, Guo Q, Guo W, Feng Y, Wang Z, Ma M, Yu Y, Wang Z, Zhang S, Wang C, Zhao W, Liu S, Song X, Liu H, Cao L (2022) Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice. Cell Rep 40(2):111062. https://doi.org/10.1016/j.celrep.2022.111062 · DOI · Paper page
  3. Biella G, Fusco F, Nardo E, Bernocchi O, Colombo A, Lichtenthaler SF, Forloni G, Albani D (2016) Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-β protein precursor processing in two Alzheimer’s disease mouse models. J Alzheimers Dis 53(3):1193–1207. https://doi.org/10.3233/JAD-151135 · DOI · Paper page
  4. Bose P, Dai Y, Grant S (2014) Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights. Pharmacol Ther 143(3):323–336. https://doi.org/10.1016/j.pharmthera.2014.04.004 · DOI · Paper page
  5. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 5(8):e201. https://doi.org/10.1371/journal.pbio.0050201 · DOI · Paper page
  6. Chen H, Wu D, Ding X, Ying W (2015) SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. NeuroReport 26(2):88–93. https://doi.org/10.1097/WNR.0000000000000305 · DOI
  7. Chen X, Lu W, Wu D (2021) Sirtuin 2 (SIRT2): Confusing roles in the pathophysiology of neurological disorders. Front Neurosci 15:614107. https://doi.org/10.3389/fnins.2021.614107 · DOI
  8. Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, Cipicchio PM, Lauver MA, Choi SH, Silverman RB, Ferrante RJ, Hersch S, Kazantsev AG (2012) The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington’s disease mouse models. Cell Rep 2(6):1492–1497. https://doi.org/10.1016/j.celrep.2012.11.001 · DOI · Paper page
  9. Ciarlo E, Heinonen T, Théroude C, Herderschee J, Mombelli M, Lugrin J, Pfefferlé M, Tyrrell B, Lensch S, Acha-Orbea H, Le Roy D, Auwerx J, Roger T (2017) Sirtuin 2 deficiency increases bacterial phagocytosis by macrophages and protects from chronic staphylococcal infection. Front Immunol 28(8):1037. https://doi.org/10.3389/fimmu.2017.01037 · DOI
  10. de Oliveira RM, Vicente Miranda H, Francelle L, Pinho R, Szegö ÉM, Martinho R, Munari F, Lázaro DF, Moniot S, Guerreiro P, Fonseca-Ornelas L, Marijanovic Z, Antas P, Gerhardt E, Enguita FJ, Fauvet B, Penque D, Pais TF, Tong Q, Becker S, Kügler S, Lashuel HA, Steegborn C, Zweckstetter M, Outeiro TF (2017) The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol. 15(3):e2000374. https://doi.org/10.1371/journal.pbio.2000374. Erratum in: PLoS Biol. 2017 Apr 5;15(4):e1002601 · DOI · Paper page
  11. Diaz-Perdigon T, Belloch FB, Ricobaraza A, Elboray EE, Suzuki T, Tordera RM, Puerta E (2020) Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model. Neuropsychopharmacology 45(2):347–357. https://doi.org/10.1038/s41386-019-0503-8 · DOI · Paper page
  12. Eratne D, Loi SM, Farrand S, Kelso W, Velakoulis D, Looi JC (2018) Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis. Australas Psychiatry 26(4):347–357. https://doi.org/10.1177/1039856218762308 · DOI · Paper page
  13. Erburu M, Muñoz-Cobo I, Diaz-Perdigon T, Mellini P, Suzuki T, Puerta E, Tordera RM (2017) SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 1(117):195–208. https://doi.org/10.1016/j.neuropharm.2017.01.033 · DOI · Paper page
  14. Esteves AR, Palma AM, Gomes R, Santos D, Silva DF, Cardoso SM (2019) Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer’s and Parkinson disease pathology. Biochim Biophys Acta Mol Basis Dis 1865(8):2008–2023. https://doi.org/10.1016/j.bbadis.2018.11.014 · DOI · Paper page
  15. Gaetani L, Bellomo G, Parnetti L, Blennow K, Zetterberg H, Di Filippo M (2021) Neuroinflammation and Alzheimer’s disease: a machine learning approach to CSF proteomics. Cells 10(8):1930. https://doi.org/10.3390/cells10081930 · DOI
  16. Goikolea J, Gerenu G, Daniilidou M, Mangialasche F, Mecocci P, Ngandu T, Rinne J, Solomon A, Kivipelto M, Cedazo-Minguez A, Sandebring-Matton A, Maioli S (2022) Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD. Alzheimers Res Ther 14(1):37. https://doi.org/10.1186/s13195-022-00979-9 · DOI
  17. Gray SC, Kinghorn KJ, Woodling NS (2020) Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis. Neural Regen Res 15(7):1208–1219. https://doi.org/10.4103/1673-5374.272571 · DOI · Paper page
  18. Guclu E, Inan SY, Vural HC (2022) The sirtuin 2 inhibitor AK-7 leads to an antidepressant-like effect in mice via upregulation of CREB1, BDNF, and NTRK2 pathways. Mol Neurobiol. https://doi.org/10.1007/s12035-022-03026-8 · DOI · Paper page
  19. He M, Chiang HH, Luo H, Zheng Z, Qiao Q, Wang L, Tan M, Ohkubo R, Mu WC, Zhao S, Wu H, Chen D (2020) An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance. Cell Metab 31(3):580-591.e5. https://doi.org/10.1016/j.cmet.2020.01.009 · DOI · Paper page
  20. Jayasena T, Poljak A, Braidy N, Zhong L, Rowlands B, Muenchhoff J, Grant R, Smythe G, Teo C, Raftery M, Sachdev P (2016) Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system. Sci Rep 20(6):35391. https://doi.org/10.1038/srep35391 · DOI · Paper page
  21. Jiao F, Wang Y, Zhang W, Zhang H, Chen Q, Wang L, Shi C, Gong Z (2020) AGK2 alleviates lipopolysaccharide induced neuroinflammation through regulation of mitogen-activated protein kinase phosphatase-1. J Neuroimmune Pharmacol 15(2):196–208. https://doi.org/10.1007/s11481-019-09890-x · DOI
  22. Johnson D, Walmsley R (2013) Histone-deacetylase inhibitors produce positive results in the GADD45a-GFP GreenScreen HC assay. Mutat Res 751(2):96–100. https://doi.org/10.1016/j.mrgentox.2012.12.009 · DOI
  23. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, Kadowaki T (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281(36):26602–26614. https://doi.org/10.1074/jbc.M601284200 · DOI · Paper page
  24. Lau SF, Wu W, Seo H, Fu AKY, Ip NY (2021) Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer’s disease mouse model. STAR Protoc 2(1):100265. https://doi.org/10.1016/j.xpro.2020.100265 · DOI
  25. Lee AS, Jung YJ, Kim D, Nguyen-Thanh T, Kang KP, Lee S, Park SK, Kim W (2014) SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochem Biophys Res Commun 450(4):1363–1369. https://doi.org/10.1016/j.bbrc.2014.06.135 · DOI
  26. Liu G, Park SH, Imbesi M, Nathan WJ, Zou X, Zhu Y, Jiang H, Parisiadou L, Gius D (2017) Loss of NAD-dependent protein deacetylase sirtuin-2 alters mitochondrial protein acetylation and dysregulates mitophagy. Antioxid Redox Signal 26(15):849–863. https://doi.org/10.1089/ars.2016.666 · doi:10.1089/ars.2016.666
  27. Lo Sasso G, Menzies KJ, Mottis A, Piersigilli A, Perino A, Yamamoto H, Schoonjans K, Auwerx J (2014) SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS One 9(7):e103573. https://doi.org/10.1371/journal.pone.0103573 · DOI
  28. Luthi-Carter R, Taylor DM, Pallos J, Lambert E, Amore A, Parker A, Moffitt H, Smith DL, Runne H, Gokce O, Kuhn A, Xiang Z, Maxwell MM, Reeves SA, Bates GP, Neri C, Thompson LM, Marsh JL, Kazantsev AG (2010) SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci U S A 107(17):7927–7932. https://doi.org/10.1073/pnas.1002924107 · DOI · Paper page
  29. Márquez-Ropero M, Benito E, Plaza-Zabala A, Sierra A (2020) Microglial corpse clearance: Lessons from macrophages. Front Immunol 27(11):506. https://doi.org/10.3389/fimmu.2020.00506 · DOI
  30. Maxwell MM, Tomkinson EM, Nobles J, Wizeman JW, Amore AM, Quinti L, Chopra V, Hersch SM, Kazantsev AG (2011) The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 20(20):3986–3996. https://doi.org/10.1093/hmg/ddr326 · DOI · Paper page
  31. Meng SX, Wang B, Li WT (2020) Intermittent hypoxia improves cognition and reduces anxiety-related behavior in APP/PS1 mice. Brain Behav 10(2):e01513. https://doi.org/10.1002/brb3.1513. Epub 2019 Dec 26 · DOI
  32. Muñoz-Cobo I, Belloch FB, Díaz-Perdigón T, Puerta E, Tordera RM (2017) SIRT2 inhibition reverses anhedonia in the VGLUT1+/- depression model. Behav Brain Res 29(335):128–131. https://doi.org/10.1016/j.bbr.2017.07.045 · DOI
  33. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11(2):437–444. https://doi.org/10.1016/s1097-2765(03)00038-8 · DOI · Paper page
  34. North BJ, Rosenberg MA, Jeganathan KB, Hafner AV, Michan S, Dai J, Baker DJ, Cen Y, Wu LE, Sauve AA, van Deursen JM, Rosenzweig A, Sinclair DA (2014) SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J 33(13):1438–1453. https://doi.org/10.15252/embj.201386907 · DOI · Paper page
  35. Olaharski AJ, Ji Z, Woo JY, Lim S, Hubbard AE, Zhang L, Smith MT (2006) The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro. Toxicol Sci 93(2):341–347. https://doi.org/10.1093/toxsci/kfl068 · DOI
  36. Olesen LØ, Bouzinova EV, Severino M, Sivasaravanaparan M, Hasselstrøm JB, Finsen B, Wiborg O (2016) Behavioural phenotyping of APPswe/PS1δE9 Mice: Age-rrelated changes and effect of long-term paroxetine treatment. PLoS One 11(11):e0165144. https://doi.org/10.1371/journal.pone.0165144 · DOI
  37. Pais TF, Szegő ÉM, Marques O, Miller-Fleming L, Antas P, Guerreiro P, de Oliveira RM, Kasapoglu B, Outeiro TF (2013) The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 32(19):2603–2616. https://doi.org/10.1038/emboj.2013.200 · DOI · Paper page
  38. Park MH, Lee M, Nam G, Kim M, Kang J, Choi BJ, Jeong MS, Park KH, Han WH, Tak E, Kim MS, Lee J, Lin Y, Lee YH, Song IS, Choi MK, Lee JY, Jin HK, Bae JS, Lim MH (2019) N, N’-Diacetyl-p-phenylenediamine restores microglial phagocytosis and improves cognitive defects in Alzheimer’s disease transgenic mice. Proc Natl Acad Sci U S A 116(47):23426–23436. https://doi.org/10.1073/pnas.1916318116 · DOI
  39. Rack JG, VanLinden MR, Lutter T, Aasland R, Ziegler M (2014) Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform. J Mol Biol 426(8):1677–1691. https://doi.org/10.1016/j.jmb.2013.10.027 · DOI
  40. Reiserer RS, Harrison FE, Syverud DC, McDonald MP (2007) Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer’s disease. Genes Brain Behav 6(1):54–65. https://doi.org/10.1111/j.1601-183X.2006.00221.x · DOI · Paper page
  41. Rosenberg A, Solomon A, Jelic V, Hagman G, Bogdanovic N, Kivipelto M (2019) Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid. Alzheimers Res Ther 11(1):99. https://doi.org/10.1186/s13195-019-0557-1 · DOI
  42. Rothgiesser KM, Erener S, Waibel S, Lüscher B, Hottiger MO (2010) SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci 123(Pt 24):4251–8. https://doi.org/10.1242/jcs.073783. Epub 2010 Nov 16. Erratum in: J Cell Sci. 2019 Apr 24;132(8) · DOI · Paper page
  43. Shen Y, Chen L, Zhang S, Xie L (2020) Correlation between SIRT2 3’UTR gene polymorphism and the susceptibility to Alzheimer’s Disease. J Mol Neurosci 70(6):878–886. https://doi.org/10.1007/s12031-020-01513-y · DOI
  44. Silva DF, Esteves AR, Oliveira CR, Cardoso SM (2017) Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer’s-disease related pathology. Mol Neurobiol 54(6):4021–4040. https://doi.org/10.1007/s12035-016-9951-x · DOI
  45. Sola-Sevilla N, Puerta E (2024) SIRT2 as a potential new therapeutic target for Alzheimer’s disease. Neural Regen Res 19(1):124–131. https://doi.org/10.4103/1673-5374.375315 · DOI
  46. Sola-Sevilla N, Ricobaraza A, Hernandez-Alcoceba R, Aymerich MS, Tordera RM, Puerta E (2021) Understanding the potential role of sirtuin 2 on aging: Consequences of SIRT2.3 overexpression in senescence. Int J Mol Sci 22(6):3107. https://doi.org/10.3390/ijms22063107 · DOI
  47. Spires-Jones TL, Fox LM, Rozkalne A, Pitstick R, Carlson GA, Kazantsev AG (2012) Inhibition of sirtuin 2 with sulfobenzoic acid derivative ak1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia. Front Pharmacol 12(3):42. https://doi.org/10.3389/fphar.2012.00042 · DOI
  48. Sun S, Han X, Li X, Song Q, Lu M, Jia M, Ding J, Hu G (2018) MicroRNA-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson’s disease. Front Mol Neurosci 11(11):381. https://doi.org/10.3389/fnmol.2018.00381 · DOI · Paper page
  49. Suzuki T, Khan MN, Sawada H, Imai E, Itoh Y, Yamatsuta K, Tokuda N, Takeuchi J, Seko T, Nakagawa H, Miyata N (2012) Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem 55(12):5760–5773. https://doi.org/10.1021/jm3002108 · DOI
  50. Wang B, Zhang Y, Cao W, Wei X, Chen J, Ying W (2016) SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice. Neurochem Res 41(9):2490–2500. https://doi.org/10.1007/s11064-016-1981-2 · DOI
  51. Wang G, Li S, Gilbert J, Gritton HJ, Wang Z, Li Z, Han X, Selkoe DJ, Man HY (2017) Crucial roles for SIRT2 and AMPA receptor acetylation in synaptic plasticity and memory. Cell Rep 20(6):1335–1347. https://doi.org/10.1016/j.celrep.2017.07.030 · DOI · Paper page
  52. Wang Y, Yang J, Hong T, Chen X, Cui L (2019) SIRT2: Controversy and multiple roles in disease and physiology. Ageing Res Rev 55:100961. https://doi.org/10.1016/j.arr.2019.100961 · DOI · Paper page
  53. Wang Y, Yang JQ, Hong TT, Sun YH, Huang HL, Chen F, Chen XJ, Chen HY, Dong SS, Cui LL, Yang TL (2020) RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer’s disease mouse model. Aging Cell 19(8):e13194. https://doi.org/10.1111/acel.13194 · DOI · Paper page
  54. Wongchitrat P, Pakpian N, Kitidee K, Phopin K, Dharmasaroja PA, Govitrapong P (2019) Alterations in the expression of amyloid precursor protein cleaving enzymes mRNA in Alzheimer peripheral blood. Curr Alzheimer Res 16(1):29–38. https://doi.org/10.2174/1567205015666181109103742 · DOI
  55. Wu Z, Zhang Y, Zhang Y, Zhao P (2020) Sirtuin 2 inhibition attenuates sevoflurane-induced learning and memory deficits in developing rats via modulating microglial activation. Cell Mol Neurobiol 40(3):437–446. https://doi.org/10.1007/s10571-019-00746-9 · DOI
  56. Yoo EJ, Lee BM (2005) Comparative mutagenicity of apicidin and apicidin derivatives (SD-0203 and SD-2007), histone deacetylase inhibitors. J Toxicol Environ Health A 68(23–24):2097–2109. https://doi.org/10.1080/15287390500182511 · DOI
  57. Yuan F, Xu ZM, Lu LY, Nie H, Ding J, Ying WH, Tian HL (2016) SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation. J Neurochem 136(3):581–593. https://doi.org/10.1111/jnc.13423 · DOI
  58. Yudoh K, Karasawa R, Ishikawa J (2015) Age-related decrease of sirtuin 2 protein in human peripheral blood mononuclear cells. Curr Aging Sci 8(3):256–258. https://doi.org/10.2174/1874609808999150831112939.Erratum.In:CurrAgingSci.2016;9(1):77 · doi:10.2174/1874609808999150831112939.erratum.in:curragingsci.2016;9(1):77
  59. Zamora-Moratalla A, Martín ED (2021) Prolactin enhances hippocampal synaptic plasticity in female mice of reproductive age. Hippocampus 31(3):281–293. https://doi.org/10.1002/hipo.23288 · DOI
  60. Zhang L, Kim S, Ren X (2020) The clinical significance of SIRT2 in malignancies: A Tumor suppressor or an oncogene? Front Oncol 8(10):1721. https://doi.org/10.3389/fonc.2020.01721 · DOI
  61. Zhang Y, Chi D (2018) Overexpression of SIRT2 alleviates neuropathic pain and neuroinflammation through deacetylation of transcription factor nuclear factor-kappa B. Inflammation 41(2):569–578. https://doi.org/10.1007/s10753-017-0713-3 · DOI

Cited by

See all 20

Metadata

Authors
Sola-Sevilla, N., Mesa-Lombardo, A., Aleixo, M., Expósito, S., Diaz-Perdigón, T., Azqueta, A., Zamani, F., Suzuki, T., Maioli, S., Eroli, F., Matton, A., Ramírez, M. J., Solas, M., Tordera, R. M., Martín, E. D., & Puerta, E.
Venue
Journal of Neuroimmune Pharmacology
Published
2023-09
Volume
18
Issue
3
Pages
529-550
ISSN
  • 1557-1890
  • 1557-1904
Cited by
20
References
6
Language
en
Licence
Funders
Universidad de Navarra

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease. https://app.cochat.ai/papers/10.1007/s11481-023-10084-9
The paper
Sola-Sevilla, N., Mesa-Lombardo, A., Aleixo, M., Expósito, S., Diaz-Perdigón, T., Azqueta, A., Zamani, F., Suzuki, T., Maioli, S., Eroli, F., Matton, A., Ramírez, M. J., Solas, M., Tordera, R. M., Martín, E. D., & Puerta, E. (2023). SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease. Journal of Neuroimmune Pharmacology. https://doi.org/10.1007/s11481-023-10084-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.